Holen Sie sich die Stockscreener-App
12.03
7.64%
-0.96
Carlsmed Inc Aktie (CARL) Neueste Nachrichten
CARL: Personalized spine surgery platform posts 86% annual growth and expands into cervical market - TradingView
CARL: Personalized spine surgery platform drives rapid growth, clinical success, and strong reimbursement - TradingView
Brokerages Set Carlsmed, Inc. (NASDAQ:CARL) Target Price at $21.33 - Defense World
Carlsmed (CARL) versus Its Peers Financial Contrast - Defense World
Analysts Offer Insights on Healthcare Companies: Addus Homecare (ADUS), Wave Life Sciences (WVE) and Carlsmed, Inc. (CARL) - The Globe and Mail
Carlsmed, Inc. (NASDAQ:CARL) Given Consensus Recommendation of "Hold" by Brokerages - MarketBeat
Carlsmed (NASDAQ:CARL) Lowered to Strong Sell Rating by Zacks Research - MarketBeat
Head to Head Survey: Carlsmed (CARL) versus Its Competitors - Defense World
Carlsmed Q4 2025 revenue up 61% to USD 15.2M - Medical Buyer
Carlsmed Q4 Earnings Call Highlights - MarketBeat
Carlsmed, Inc. Reports Strong Q4 2025 Earnings and Growth Outlook - Intellectia AI
Carlsmed Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Carlsmed Inc (NASDAQ:CARL) Reports Q4 Revenue Beat and Narrower-Than-Expected Loss - ChartMill
Earnings call transcript: Carlsmed reports strong revenue, stock dips Q4 2025 - Investing.com
Carlsmed (NASDAQ:CARL) Issues Quarterly Earnings Results - MarketBeat
CARL: 2025 revenue surged 86% with expanding margins and strong adoption of new spine surgery products - TradingView
CARL: 2025 revenue surged 86% with expanding margins; 2026 guidance targets $70–$75M and robust growth - TradingView
Carlsmed® Reports Fourth Quarter and Full Year 2025 Financial Results - The Manila Times
Carlsmed, Inc. Provides Revenue Guidance for the Year 2026 - marketscreener.com
Head to Head Comparison: Carlsmed (CARL) versus Its Competitors - Defense World
Carlsmed announces clinical debuts of two spinal surgery solutions - Today's Medical Developments
Carlsmed Reports Fourth Quarter and Full Year 2025 Financial Results - Bitget
Carlsmed Unveils Custom Cervical Plating Tech - National Today
Carlsmed Inc expected to post a loss of 43 cents a shareEarnings Preview - TradingView
Carlsmed, Inc. To Participate in the 2026 Canaccord Genuity Musculoskeletal Conference - marketscreener.com
Head to Head Survey: Carlsmed (NASDAQ:CARL) & Check-Cap (NASDAQ:MBAI) - Defense World
Financial Contrast: Carlsmed (CARL) and Its Competitors - Defense World
Carlsmed Announces first corra™ personalized Cervical Plating Procedure - Orthopedics This Week
Carlsmed Announces first corra personalized Cervical Plating Procedure - Bitget
Analyzing Carlsmed (CARL) & Its Competitors - Defense World
CARL Should I Buy - Intellectia AI
Wall Street Zen Upgrades Carlsmed (NASDAQ:CARL) to “Hold” - Defense World
Financial Review: Carlsmed (CARL) versus Its Rivals - Defense World
Critical Comparison: Carlsmed (NASDAQ:CARL) vs. TransEnterix (OTCMKTS:TRXDW) - Defense World
Carlsmed Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026 - The Manila Times
Carlsmed completes first surgery using aprevo bilateral posterior system By Investing.com - Investing.com Canada
Carlsmed completes first surgery using aprevo bilateral posterior system - Investing.com Nigeria
Carlsmed Announces First aprevo® Bi-lateral Posterior Lumbar Interbody Fusion Procedure - Orthopedics This Week
Both private equity firms who control a good portion of Carlsmed, Inc. (NASDAQ:CARL) along with institutions must be dismayed after last week's 11% decrease - simplywall.st
TD Waterhouse Canada Inc. Takes $2.03 Million Position in Carlsmed, Inc. $CARL - MarketBeat
Teacher Retirement System of Texas Purchases Shares of 175,000 Carlsmed, Inc. $CARL - MarketBeat
Financial Comparison: Carlsmed (NASDAQ:CARL) & ReShape Lifesciences (OTCMKTS:RSLSD) - Defense World
Bullish Carlsmed Insiders Loaded Up On US$8.10m Of Stock - Yahoo Finance
Analyzing Carlsmed (NASDAQ:CARL) and Perspective Therapeutics (NASDAQ:CATX) - Defense World
Carlsmed (NASDAQ:CARL) Downgraded to Sell Rating by Wall Street Zen - MarketBeat
BTIG Reiterates Buy Rating on CARL, Maintains Price Target | CAR - GuruFocus
AI medtech firm Carlsmed prices $100.5M IPO - MSN
California-based Carlsmed Q4 2025 revenue up 61% to USD 15.2M - Medical Buyer
Carlsmed reports 61% revenue growth in Q4 2025 By Investing.com - Investing.com Nigeria
2.72%
3.31%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):